TheraRadar
← Back
Data updated: Jun 28, 2026

MMT

Specialty
Pharmaceuticals

MMT is a specialty pharmaceutical company with 3 FDA-approved products.

1973
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

MMT's Key Drugs

MMT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

MMT's Recent FDA Approvals

New NDA/BLA approvals for MMT over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

MMT's Therapeutic Areas

Disease areas where MMT has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

MMT Pipeline Snapshot

Active clinical trials for MMT across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling